Cargando…

Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity

The most successful medical intervention for preventing infectious diseases is still vaccination. This effective strategy has resulted in decreased mortality and extended life expectancy. However, there is still a critical need for novel vaccination strategies and vaccines. Antigen cargo delivery by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebensen, Thomas, Arntz, Andrea, Schulze, Kai, Hanefeld, Andrea, Guzmán, Carlos A., Scherließ, Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145907/ https://www.ncbi.nlm.nih.gov/pubmed/37111723 http://dx.doi.org/10.3390/pharmaceutics15041238

Ejemplares similares

The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization
por: Ebensen, Thomas, et al.
Publicado: (2019)

Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles
por: Najafi, Adel, et al.
Publicado: (2023)

Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
por: Sanchez, Maria Victoria, et al.
Publicado: (2014)

The Mucosal Adjuvant Cyclic di-AMP Exerts Immune Stimulatory Effects on Dendritic Cells and Macrophages
por: Škrnjug, Ivana, et al.
Publicado: (2014)

Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi
por: Matos, Marina N., et al.
Publicado: (2017)

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice
por: Ebensen, Thomas, et al.
Publicado: (2017)

Cyclic GMP-AMP Displays Mucosal Adjuvant Activity in Mice
por: Škrnjug, Ivana, et al.
Publicado: (2014)

Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG
por: Sanchez, Maria Victoria, et al.
Publicado: (2023)

Mucosal Vaccination via the Respiratory Tract
por: Hellfritzsch, Marie, et al.
Publicado: (2019)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

Chitosan-based mucosal adjuvants: Sunrise on the ocean
por: Xia, Yufei, et al.
Publicado: (2015)

Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines
por: Lirussi, Darío, et al.
Publicado: (2021)

Correction: Cyclic GMP-AMP Displays Mucosal Adjuvant Activity in Mice
Publicado: (2015)

Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3′ 5′- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype
por: Quintana, Ingrid, et al.
Publicado: (2018)

Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway
por: Lirussi, Darío, et al.
Publicado: (2017)

S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice
por: Sen Chaudhuri, Arka, et al.
Publicado: (2022)

Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens
por: Canelli, Elena, et al.
Publicado: (2023)

Humoral immune and adjuvant responses of mucosally-administered Tinospora cordifolia immunomodulatory protein in BALB/c mice
por: Aranha, Ivan, et al.
Publicado: (2020)

Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune Intervention
por: Trittel, Stephanie, et al.
Publicado: (2019)

Mucosal Immunization and Adjuvants
por: Hasegawa, Hideki, et al.
Publicado: (2014)

Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid
por: Moghadam Ariaee, Faezeh, et al.
Publicado: (2012)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Purine Nucleosides Interfere with c-di-AMP Levels and Act as Adjuvants To Re-Sensitize MRSA To β-Lactam Antibiotics
por: Nolan, Aaron C., et al.
Publicado: (2022)

Injectable Thermosensitive Chitosan-Collagen Hydrogel as A Delivery System for Marine Polysaccharide Fucoidan
por: Ohmes, Julia, et al.
Publicado: (2022)

Cyclic di‐nucleotides: new era for small molecules as adjuvants
por: Libanova, Rimma, et al.
Publicado: (2012)

The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo
por: Blaauboer, Steven M, et al.
Publicado: (2015)

Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)

Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease
por: Dedloff, Margaret R., et al.
Publicado: (2019)

Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection
por: Said, Doaa E., et al.
Publicado: (2022)

Molecular adjuvant interleukin-33 enhances the antifertility effect of Lagurus lagurus zona pellucida 3 DNA vaccine administered by the mucosal route
por: Tu, Y.X., et al.
Publicado: (2013)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

In Vivo Detection of Cyclic-di-AMP in Staphylococcus aureus
por: Mukkayyan, Nagaraja, et al.
Publicado: (2022)

Cyclic-di-AMP signalling in lactic acid bacteria
por: Turner, Mark S, et al.
Publicado: (2023)

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
por: Sanchez Alberti, Andrés, et al.
Publicado: (2020)

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
por: Sanchez Alberti, Andrés, et al.
Publicado: (2017)

Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis
por: Said, Doaa E., et al.
Publicado: (2023)

CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Mucosal Adhesive Chitosan Nanogel Formulations of Antibiotics and Adjuvants (Terpenoids, Flavonoids, etc.) and Their Potential for the Treatment of Infectious Diseases of the Gastrointestinal Tract
por: Zlotnikov, Igor D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qd2trn5th7vvfve8ifvh3fafnh